High expression levels of ATP7A, CDKN2A, DLAT, DLD, DLST, GCSH, GLS, LIPT1, MTF1, PDHA1, and PDHB are the risk factors for HCC patients (Figures 3(a) and 3(b)). The gene discussed is DLST; the disease is hepatocellular carcinoma.